文献速递免疫规划卫生政策与健康促进妇幼与学校卫生

疫苗接种不足作为系统失败:2025年CDC/ACIP乙肝出生剂量政策转变及多层面干预包的蒙特卡洛模拟(2025-2035)

Under-vaccination as a systems failure: A Monte Carlo simulation of the 2025 CDC/ACIP hepatitis B birth-dose policy shift and multi-level intervention packages, 2025-2035.
PubMed 文献 · Vaccine · 2026-06-28

该研究用蒙特卡洛模拟(N=50,000次迭代)预测美国2025-2035年乙肝疫苗接种结局。结果显示仅政策情景下出生剂量覆盖率从91.8%降至75.7%,导致19,306例围产期感染;综合多层面干预可维持覆盖率89.7%并大幅减少感染。

要点

  • 仅政策情景下出生剂量覆盖率10年内从91.8%降至75.7%,产生19,306例围产期HBV感染。
  • 综合干预(常规医嘱+EHR流程+CHW外展)可维持出生剂量覆盖率89.7%、成人接种率95.0%。
  • 母亲筛查灵敏度是围产期结局最强预测因子(r=-0.909)。

核心结论

  • 2025年SCDM政策若无结构性保障,预计将降低围产期HBV保护并扩大健康差距。
  • 综合多层面干预(常规医嘱、EHR驱动流程和CHW外展)可抵消预期危害,仅政策修订不足。

研究设计与样本

  • 蒙特卡洛模拟(N=50,000次迭代),预测美国2025-2035年疫苗接种结局。
  • 设置五个情景:仅政策、医院常规医嘱、EHR驱动诊所流程优化、CHW外展、综合多层面干预。
  • 参数来源于已发表的监测数据、临床试验和实施研究。

主要发现

  • 仅政策情景下出生剂量覆盖率从91.8%降至75.7%(第10年),产生19,306例围产期HBV感染(95% CrI: 15,851-24,279)和17,376例慢性病例。
  • 综合干预情景下出生剂量覆盖率维持89.7%(95% CrI: 80.3-97.0%),成人接种率达95.0%(第10年),围产期感染降至1952例(95% CrI: 729-3869)。
  • 母亲筛查灵敏度是围产期结局最强预测因子(r=-0.909)。

临床怎么用

  • 预防医学与公共卫生智能体应支持在政策转变下强化结构性保障措施,如医院常规医嘱和EHR流程优化。
  • 建议整合CHW外展以提升成人及出生剂量疫苗接种覆盖率,保护脆弱人群。
  • 应优先保障母亲HBV筛查灵敏度以降低围产期感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2025, the CDC/ACIP reclassified the hepatitis B (HBV) birth-dose recommendation from universal vaccination to a shared clinical decision-making (SCDM) model. U.S. adult HBV vaccination rates remain stagnant at 30-32%, reflecting systemic delivery failures. The projected impact of this policy shift and whether multi-level interventions can protect vulnerable populations remains unquantified. METHODS: We developed a Monte Carlo simulation (N = 50,000 iterations) projecting U.S. vaccination outcomes from 2025 to 2035 across five scenarios: (A) policy-only; (B) hospital standing orders; (C) EHR-driven clinic workflow optimization; (D) community health worker (CHW) outreach; and (E) a comprehensive multi-level intervention. Parameters derived from published surveillance data, clinical trials, and implementation studies. Primary outcomes included birth-dose coverage, adult series completion, perinatal infections, and chronic HBV cases. RESULTS: Under Policy-Only (Scenario A), birth-dose coverage fell from 91.8% to 75.7% by Year 10, yielding 19,306 perinatal HBV infections (95% CrI: 15,851-24,279) and 17,376 chronic cases. The comprehensive intervention (Scenario E) maintained birth-dose coverage at 89.7% (95% CrI: 80.3-97.0%) and adult vaccination at 95.0% by Year 10, reducing perinatal infections to 1952 (95% CrI: 729-3869)-equivalent to 10.4 million additional adult vaccinations over Policy-Only. Maternal screening sensitivity was the strongest predictor of perinatal outcomes (r = -0.909). CONCLUSIONS: The 2025 SCDM policy, absent structural safeguards, is projected to reduce perinatal HBV protection and widen health disparities over the next decade. A comprehensive multi-level intervention-combining standing orders, EHR-driven workflows, and CHW outreach-is necessary to offset projected harm. Policy revision alone is insufficient; protecting vulnerable populations requires fundamental redesign of healthcare delivery.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gandhi V, Kinariwala K, Kesling GL, et al. Under-vaccination as a systems failure: A Monte Carlo simulation of the 2025 CDC/ACIP hepatitis B birth-dose policy shift and multi-level intervention packages, 2025-2035. Vaccine. 2026. PMID: 42365679. doi:10.1016/j.vaccine.2026.128883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。